Abbas Ebrahimi‐Kalan
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Oncology top 5%
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
Papers in
-
- RNA Interference and Gene Delivery 6
- Extracellular vesicles in disease 4
-
- Spinal Cord Injury Research 7
- Multiple Sclerosis Research Studies 4
- Co-authors
- Rana Jahanban‐Esfahlan (2 shared papers)Leila Roshangar (3 shared papers)Khaled Seidi (2 shared papers)Payman Zare (1 shared paper)Saeed Kolahian (1 shared paper)Roghayyeh Baghban (1 shared paper)Tahereh Javaheri (1 shared paper)Mehdi Jaymand (1 shared paper)
- Journals
- Advanced Pharmaceutical Bulletin (6 papers)Biomedicine & Pharmacotherapy (4 papers)Life Sciences (3 papers)Journal of Drug Delivery Science and Technology (3 papers)Bioimpacts (3 papers)
- Partner nations
- IranUnited StatesTürkiye
In The Last Decade
Abbas Ebrahimi‐Kalan
62 papers receiving 2.2k citations
Abbas Ebrahimi‐Kalan's Hit Papers
Peers
Comparison fields: 5 of 132
- Cancer Research 357
- Oncology 512
- Biomaterials 231
- Immunology 339
- Molecular Biology 714
Countries citing papers authored by Abbas Ebrahimi‐Kalan
This map shows the geographic impact of Abbas Ebrahimi‐Kalan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abbas Ebrahimi‐Kalan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abbas Ebrahimi‐Kalan more than expected).
Fields of papers citing papers by Abbas Ebrahimi‐Kalan
This network shows the impact of papers produced by Abbas Ebrahimi‐Kalan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abbas Ebrahimi‐Kalan. The network helps show where Abbas Ebrahimi‐Kalan may publish in the future.
Co-authors
The 25 scholars most cited alongside Abbas Ebrahimi‐Kalan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tumor microenvironment complexity and therapeutic implications at a glance Hit paper breakdown → | 2020 | 1277 |
| 2 | 2018 | 87 | |
| 3 | 2021 | 67 | |
| 4 | 2023 | 64 | |
| 5 | 2017 | 53 | |
| 6 | 2020 | 47 | |
| 7 | 2020 | 34 | |
| 8 | 2020 | 29 | |
| 9 | 2020 | 29 | |
| 10 | 2023 | 28 | |
| 11 | 2018 | 27 | |
| 12 | 2021 | 27 | |
| 13 | 2017 | 26 | |
| 14 | 2018 | 22 | |
| 15 | 2021 | 21 | |
| 16 | 2019 | 19 | |
| 17 | 2018 | 18 | |
| 18 | 2016 | 16 | |
| 19 | 2020 | 14 | |
| 20 | 2021 | 14 |
About Abbas Ebrahimi‐Kalan
Abbas Ebrahimi‐Kalan is a scholar working on Molecular Biology, Pathology and Forensic Medicine, Biomedical Engineering, Neurology and Immunology, having authored 69 papers that have together received 2.2k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (7 papers), Spinal Cord Injury Research (7 papers), RNA Interference and Gene Delivery (6 papers), Graphene and Nanomaterials Applications (5 papers), Multiple Sclerosis Research Studies (4 papers), Neuroinflammation and Neurodegeneration Mechanisms (4 papers), Extracellular vesicles in disease (4 papers) and Neurological Disorders and Treatments (4 papers). The work is most often cited by research in Cancer Research (357 citations), Oncology (512 citations), Biomaterials (231 citations), Immunology (339 citations) and Molecular Biology (714 citations). Abbas Ebrahimi‐Kalan has collaborated with scholars based in Iran, United States and Türkiye. Frequent co-authors include Rana Jahanban‐Esfahlan, Leila Roshangar, Khaled Seidi, Payman Zare, Saeed Kolahian, Roghayyeh Baghban, Tahereh Javaheri, Mehdi Jaymand, Ahmad Mehdipour and Mohammad Reza Alipour. Their work appears in journals such as Advanced Pharmaceutical Bulletin, Biomedicine & Pharmacotherapy, Life Sciences, Journal of Drug Delivery Science and Technology and Bioimpacts.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.